Test ID ROC Rubeola (Measles) Antibodies, IgG and IgM (Separate Determinations), Spinal Fluid
Useful For
Diagnosis of central nervous system infection with rubeola (measles) virus and/or subacute sclerosing panencephalitis
Method Name
Immunofluorescence Assay (IFA)
Reporting Name
Rubeola (Measles) Ab, IgG,IgM, CSFSpecimen Type
CSFContainer/Tube: Sterile vial
Specimen Volume: 0.25 mL
Specimen Minimum Volume
0.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
CSF | Refrigerated (preferred) | 14 days |
Frozen | 14 days |
Clinical Information
Measles is a serious and highly contagious disease which can be a leading cause of death where nutrition and sanitation are limited. Onset begins with cough, fever, and lymphadenopathy approximately 2 weeks after exposure. Diagnosis is usually made when the rash appears. Koplik’s spots may be seen earlier on the buccal mucosa. Complications of measles may develop in children who appear to have normal immune functions.
Persistent infection of the central nervous system with measles virus is recognized to cause the disease subacute sclerosing panencephalitis (SSPE). SSPE is a rare, late complication of measles with an incidence of approximately 1 per 100,000 cases. SSPE is a progressive, usually fatal disease that occurs most often in children between the ages of 5 and 14. The onset is insidious and progressive. The incubation period from acute measles to onset of neurological symptoms varies from several months to many years. One of the most useful diagnostic tests involves the measurement of measles-specific antibodies in the cerebrospinal fluid (CSF) of patients with SSPE. Levels of antibody are significantly elevated in the CSF of SSPE patients compared to those without the disease.
Reference Values
IgG: <1:5
IgM: <1:10
Cautions
Detection of organism-specific antibodies in the cerebrospinal fluid (CSF) may suggest central nervous system infection. However, these results are unable to distinguish between intrathecal antibodies and serum antibodies introduced into the CSF at the time of lumbar puncture or from a breakdown in the blood-brain barrier. The results should be interpreted with other laboratory and clinical data prior to a diagnosis of central nervous system infection.
Day(s) Performed
Monday through Friday; 9 a.m.
Report Available
1 dayPerforming Laboratory

Test Classification
This test has been modified from the manufacturer’s instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86765 x 2